Monkeypox Variants Get New Names 12/08/2022 Editorial team While the process of renaming monkeypox is still underway, a group of global experts convened by the World Health Organization (WHO) has agreed that the virus’s variants will be renamed with Roman numerals. This follows a meeting convened by the WHO this week to enable virologists and public health experts to reach consensus on new […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Treatment Says There’s No Shortage and Will Work with WHO on Supplies 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> US to Stretch Monkeypox Vaccine Supply Through Intradermal Injections; Experts Warn Plan May Backfire 10/08/2022 Raisa Santos In the aftermath of a national health emergency declaration for Monkeypox, the United States has now decided to split the approved MVA-BN vaccine into five doses in an effort to stretch supply. Some experts, however, have warned that the plan may backfire if health workers are not sufficiently trained in the intradermal skin-based jab technique […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, faces a planned closure of its European production plant until late 2022. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how the company plans to meet rising demand for its monkeypox vaccine following the global health emergency […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> World Needs 180,000 – 360,000 Monkeypox Vaccine Doses For People Exposed – Up to 10 million for High Risk Groups 27/07/2022 Elaine Ruth Fletcher About 10% of people with Monkeypox require hospitalization and children are at the highest risk of severe disease, says WHO. Meanwhile, there are only about 1 million doses of the EMA and US FDA-approved MVA-BN vaccine readily available today across the globe – but that vaccine is also untested against monkeypox at large scale. The […] Continue reading -> WHO’s European Region, The Monkeypox ‘Hotspot’, Asks Countries to ‘Act with Urgency’ 26/07/2022 Elaine Ruth Fletcher WHO’s Regional Director for Europe, Hans Kluge, has asked the 53 countries in the WHO region to “act with urgency” in halting the Monkeypox emergency that has hit the region hardest – noting that “vaccines alone won’t end the outbreak”. Kluge’s statement Tuesday followed Saturday’s declaration by WHO of a global public health emergency over […] Continue reading -> WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak 23/07/2022 Elaine Ruth Fletcher WHO has declared a new global public health emergency over the Monkeypox outbreak which has now spread to more than 16,000 people in over 75 countries and territories – in what some public health experts described as a “bold decision” by Director General Dr Tedros Adhanom Ghebreyesus, overriding a divided group of expert advisors. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Manufacturer of World’s Only Monkeypox Treatment Says There’s No Shortage and Will Work with WHO on Supplies 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> US to Stretch Monkeypox Vaccine Supply Through Intradermal Injections; Experts Warn Plan May Backfire 10/08/2022 Raisa Santos In the aftermath of a national health emergency declaration for Monkeypox, the United States has now decided to split the approved MVA-BN vaccine into five doses in an effort to stretch supply. Some experts, however, have warned that the plan may backfire if health workers are not sufficiently trained in the intradermal skin-based jab technique […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, faces a planned closure of its European production plant until late 2022. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how the company plans to meet rising demand for its monkeypox vaccine following the global health emergency […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> World Needs 180,000 – 360,000 Monkeypox Vaccine Doses For People Exposed – Up to 10 million for High Risk Groups 27/07/2022 Elaine Ruth Fletcher About 10% of people with Monkeypox require hospitalization and children are at the highest risk of severe disease, says WHO. Meanwhile, there are only about 1 million doses of the EMA and US FDA-approved MVA-BN vaccine readily available today across the globe – but that vaccine is also untested against monkeypox at large scale. The […] Continue reading -> WHO’s European Region, The Monkeypox ‘Hotspot’, Asks Countries to ‘Act with Urgency’ 26/07/2022 Elaine Ruth Fletcher WHO’s Regional Director for Europe, Hans Kluge, has asked the 53 countries in the WHO region to “act with urgency” in halting the Monkeypox emergency that has hit the region hardest – noting that “vaccines alone won’t end the outbreak”. Kluge’s statement Tuesday followed Saturday’s declaration by WHO of a global public health emergency over […] Continue reading -> WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak 23/07/2022 Elaine Ruth Fletcher WHO has declared a new global public health emergency over the Monkeypox outbreak which has now spread to more than 16,000 people in over 75 countries and territories – in what some public health experts described as a “bold decision” by Director General Dr Tedros Adhanom Ghebreyesus, overriding a divided group of expert advisors. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US to Stretch Monkeypox Vaccine Supply Through Intradermal Injections; Experts Warn Plan May Backfire 10/08/2022 Raisa Santos In the aftermath of a national health emergency declaration for Monkeypox, the United States has now decided to split the approved MVA-BN vaccine into five doses in an effort to stretch supply. Some experts, however, have warned that the plan may backfire if health workers are not sufficiently trained in the intradermal skin-based jab technique […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, faces a planned closure of its European production plant until late 2022. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how the company plans to meet rising demand for its monkeypox vaccine following the global health emergency […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> World Needs 180,000 – 360,000 Monkeypox Vaccine Doses For People Exposed – Up to 10 million for High Risk Groups 27/07/2022 Elaine Ruth Fletcher About 10% of people with Monkeypox require hospitalization and children are at the highest risk of severe disease, says WHO. Meanwhile, there are only about 1 million doses of the EMA and US FDA-approved MVA-BN vaccine readily available today across the globe – but that vaccine is also untested against monkeypox at large scale. The […] Continue reading -> WHO’s European Region, The Monkeypox ‘Hotspot’, Asks Countries to ‘Act with Urgency’ 26/07/2022 Elaine Ruth Fletcher WHO’s Regional Director for Europe, Hans Kluge, has asked the 53 countries in the WHO region to “act with urgency” in halting the Monkeypox emergency that has hit the region hardest – noting that “vaccines alone won’t end the outbreak”. Kluge’s statement Tuesday followed Saturday’s declaration by WHO of a global public health emergency over […] Continue reading -> WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak 23/07/2022 Elaine Ruth Fletcher WHO has declared a new global public health emergency over the Monkeypox outbreak which has now spread to more than 16,000 people in over 75 countries and territories – in what some public health experts described as a “bold decision” by Director General Dr Tedros Adhanom Ghebreyesus, overriding a divided group of expert advisors. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, faces a planned closure of its European production plant until late 2022. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how the company plans to meet rising demand for its monkeypox vaccine following the global health emergency […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> World Needs 180,000 – 360,000 Monkeypox Vaccine Doses For People Exposed – Up to 10 million for High Risk Groups 27/07/2022 Elaine Ruth Fletcher About 10% of people with Monkeypox require hospitalization and children are at the highest risk of severe disease, says WHO. Meanwhile, there are only about 1 million doses of the EMA and US FDA-approved MVA-BN vaccine readily available today across the globe – but that vaccine is also untested against monkeypox at large scale. The […] Continue reading -> WHO’s European Region, The Monkeypox ‘Hotspot’, Asks Countries to ‘Act with Urgency’ 26/07/2022 Elaine Ruth Fletcher WHO’s Regional Director for Europe, Hans Kluge, has asked the 53 countries in the WHO region to “act with urgency” in halting the Monkeypox emergency that has hit the region hardest – noting that “vaccines alone won’t end the outbreak”. Kluge’s statement Tuesday followed Saturday’s declaration by WHO of a global public health emergency over […] Continue reading -> WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak 23/07/2022 Elaine Ruth Fletcher WHO has declared a new global public health emergency over the Monkeypox outbreak which has now spread to more than 16,000 people in over 75 countries and territories – in what some public health experts described as a “bold decision” by Director General Dr Tedros Adhanom Ghebreyesus, overriding a divided group of expert advisors. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, faces a planned closure of its European production plant until late 2022. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how the company plans to meet rising demand for its monkeypox vaccine following the global health emergency […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> World Needs 180,000 – 360,000 Monkeypox Vaccine Doses For People Exposed – Up to 10 million for High Risk Groups 27/07/2022 Elaine Ruth Fletcher About 10% of people with Monkeypox require hospitalization and children are at the highest risk of severe disease, says WHO. Meanwhile, there are only about 1 million doses of the EMA and US FDA-approved MVA-BN vaccine readily available today across the globe – but that vaccine is also untested against monkeypox at large scale. The […] Continue reading -> WHO’s European Region, The Monkeypox ‘Hotspot’, Asks Countries to ‘Act with Urgency’ 26/07/2022 Elaine Ruth Fletcher WHO’s Regional Director for Europe, Hans Kluge, has asked the 53 countries in the WHO region to “act with urgency” in halting the Monkeypox emergency that has hit the region hardest – noting that “vaccines alone won’t end the outbreak”. Kluge’s statement Tuesday followed Saturday’s declaration by WHO of a global public health emergency over […] Continue reading -> WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak 23/07/2022 Elaine Ruth Fletcher WHO has declared a new global public health emergency over the Monkeypox outbreak which has now spread to more than 16,000 people in over 75 countries and territories – in what some public health experts described as a “bold decision” by Director General Dr Tedros Adhanom Ghebreyesus, overriding a divided group of expert advisors. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, faces a planned closure of its European production plant until late 2022. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how the company plans to meet rising demand for its monkeypox vaccine following the global health emergency […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> World Needs 180,000 – 360,000 Monkeypox Vaccine Doses For People Exposed – Up to 10 million for High Risk Groups 27/07/2022 Elaine Ruth Fletcher About 10% of people with Monkeypox require hospitalization and children are at the highest risk of severe disease, says WHO. Meanwhile, there are only about 1 million doses of the EMA and US FDA-approved MVA-BN vaccine readily available today across the globe – but that vaccine is also untested against monkeypox at large scale. The […] Continue reading -> WHO’s European Region, The Monkeypox ‘Hotspot’, Asks Countries to ‘Act with Urgency’ 26/07/2022 Elaine Ruth Fletcher WHO’s Regional Director for Europe, Hans Kluge, has asked the 53 countries in the WHO region to “act with urgency” in halting the Monkeypox emergency that has hit the region hardest – noting that “vaccines alone won’t end the outbreak”. Kluge’s statement Tuesday followed Saturday’s declaration by WHO of a global public health emergency over […] Continue reading -> WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak 23/07/2022 Elaine Ruth Fletcher WHO has declared a new global public health emergency over the Monkeypox outbreak which has now spread to more than 16,000 people in over 75 countries and territories – in what some public health experts described as a “bold decision” by Director General Dr Tedros Adhanom Ghebreyesus, overriding a divided group of expert advisors. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> World Needs 180,000 – 360,000 Monkeypox Vaccine Doses For People Exposed – Up to 10 million for High Risk Groups 27/07/2022 Elaine Ruth Fletcher About 10% of people with Monkeypox require hospitalization and children are at the highest risk of severe disease, says WHO. Meanwhile, there are only about 1 million doses of the EMA and US FDA-approved MVA-BN vaccine readily available today across the globe – but that vaccine is also untested against monkeypox at large scale. The […] Continue reading -> WHO’s European Region, The Monkeypox ‘Hotspot’, Asks Countries to ‘Act with Urgency’ 26/07/2022 Elaine Ruth Fletcher WHO’s Regional Director for Europe, Hans Kluge, has asked the 53 countries in the WHO region to “act with urgency” in halting the Monkeypox emergency that has hit the region hardest – noting that “vaccines alone won’t end the outbreak”. Kluge’s statement Tuesday followed Saturday’s declaration by WHO of a global public health emergency over […] Continue reading -> WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak 23/07/2022 Elaine Ruth Fletcher WHO has declared a new global public health emergency over the Monkeypox outbreak which has now spread to more than 16,000 people in over 75 countries and territories – in what some public health experts described as a “bold decision” by Director General Dr Tedros Adhanom Ghebreyesus, overriding a divided group of expert advisors. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Needs 180,000 – 360,000 Monkeypox Vaccine Doses For People Exposed – Up to 10 million for High Risk Groups 27/07/2022 Elaine Ruth Fletcher About 10% of people with Monkeypox require hospitalization and children are at the highest risk of severe disease, says WHO. Meanwhile, there are only about 1 million doses of the EMA and US FDA-approved MVA-BN vaccine readily available today across the globe – but that vaccine is also untested against monkeypox at large scale. The […] Continue reading -> WHO’s European Region, The Monkeypox ‘Hotspot’, Asks Countries to ‘Act with Urgency’ 26/07/2022 Elaine Ruth Fletcher WHO’s Regional Director for Europe, Hans Kluge, has asked the 53 countries in the WHO region to “act with urgency” in halting the Monkeypox emergency that has hit the region hardest – noting that “vaccines alone won’t end the outbreak”. Kluge’s statement Tuesday followed Saturday’s declaration by WHO of a global public health emergency over […] Continue reading -> WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak 23/07/2022 Elaine Ruth Fletcher WHO has declared a new global public health emergency over the Monkeypox outbreak which has now spread to more than 16,000 people in over 75 countries and territories – in what some public health experts described as a “bold decision” by Director General Dr Tedros Adhanom Ghebreyesus, overriding a divided group of expert advisors. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO’s European Region, The Monkeypox ‘Hotspot’, Asks Countries to ‘Act with Urgency’ 26/07/2022 Elaine Ruth Fletcher WHO’s Regional Director for Europe, Hans Kluge, has asked the 53 countries in the WHO region to “act with urgency” in halting the Monkeypox emergency that has hit the region hardest – noting that “vaccines alone won’t end the outbreak”. Kluge’s statement Tuesday followed Saturday’s declaration by WHO of a global public health emergency over […] Continue reading -> WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak 23/07/2022 Elaine Ruth Fletcher WHO has declared a new global public health emergency over the Monkeypox outbreak which has now spread to more than 16,000 people in over 75 countries and territories – in what some public health experts described as a “bold decision” by Director General Dr Tedros Adhanom Ghebreyesus, overriding a divided group of expert advisors. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak 23/07/2022 Elaine Ruth Fletcher WHO has declared a new global public health emergency over the Monkeypox outbreak which has now spread to more than 16,000 people in over 75 countries and territories – in what some public health experts described as a “bold decision” by Director General Dr Tedros Adhanom Ghebreyesus, overriding a divided group of expert advisors. The […] Continue reading -> Posts navigation Older posts